Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer.
Sequential treatment with endocrine or chemotherapy is generally used in the treatment of estrogen receptor (ER)-positive recurrent breast cancer. To date, few studies have investigated the effect of long-term endocrine therapy on the response to subsequent chemotherapy in ER-positive breast cancer....
Saved in:
| Main Authors: | Takayuki Watanabe, Takaaki Oba, Keiji Tanimoto, Tomohiro Shibata, Shinobu Kamijo, Ken-Ichi Ito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0252822&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
by: Renée de Leeuw, et al.
Published: (2011-01-01) -
Tamoxifen Molecular Targets Different From Estrogen Receptors
by: T. A. Bogush, et al.
Published: (2020-05-01) -
New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy
by: T. A. Bogush, et al.
Published: (2020-05-01) -
PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells
by: Wenju Mo, et al.
Published: (2025-06-01) -
Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
by: Wan-Xin Peng, et al.
Published: (2021-10-01)